Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c pseudogene 6 (CYCSP6, also known as HCP6) is one of a large family of processed pseudogenes derived from the functional cytochrome c (CYCS) gene in the human genome[1][5]. Like other pseudogenes, CYCSP6 has significant sequence similarity to the parent gene but is nonfunctional: it does not produce an active protein product due to disabling mutations, frameshifts, or absence of regulatory elements required for expression[2][1][5]. CYCSP6 is not considered a therapeutic target, nor is it involved in canonical biological functions or disease mechanisms attributed to functional cytochrome c[1][5]. The gene is classified as a pseudogene rather than an active gene product or receptor, meaning it does not code for a functioning protein and thus lacks canonical biochemical, pharmacological, or clinical relevance[2][1][5]. This disqualifies it as a direct therapeutic target. Pseudogenes such as CYCSP6 are sometimes studied for their evolutionary significance or as markers of genomic duplication events, but they are not involved in cell signaling, metabolism, or disease as active proteins[2][7]. Cytochrome c itself is a small heme protein with essential roles in electron transport and apoptosis, but this function pertains to the functional CYCS gene locus, not to its pseudogenes[4]. CYCSP6 (CYCS pseudogene 6, HCP6) is a nonfunctional genetic relic related to cytochrome c, and is not a molecular target in the context of pharmacology or biology[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c pseudogene 6 (CYCSP6).